Wai Chan
About Wai Chan
Wai Chan is the Director of Clinical Science at BeiGene in San Mateo, with prior experience at Genentech, Bristol-Myers Squibb, UCSF, and Eli Lilly and Company.
Current Role at BeiGene
Wai Chan is currently serving as the Director of Clinical Science at BeiGene, a position held since January 2018. Based in San Mateo, Chan is responsible for overseeing clinical research and development activities. His role includes monitoring clinical trials, coordinating with research teams, and ensuring compliance with regulatory standards. Chan's extensive background in clinical sciences provides a robust foundation for his contributions to BeiGene's ongoing projects.
Previous Experience at Genentech
Before joining BeiGene, Wai Chan worked at Genentech as a Clinical Science Specialist. His tenure at Genentech spanned five years, from 2013 to 2018, in the San Francisco Bay Area. During his time there, Chan was involved in various clinical development projects, contributing to the advancement of therapeutic programs. His experience with large-scale clinical trials and data analysis significantly supported Genentech's research objectives.
Tenure at Bristol-Myers Squibb
Wai Chan served as a Senior Clinical Scientist at Bristol-Myers Squibb from 2007 to 2013, a six-year period. In this role, Chan focused on the clinical development phases of pharmaceutical products, from planning and design to execution and reporting. His responsibilities included cross-functional collaboration with various departments to ensure the accuracy and integrity of clinical data. Chan's work contributed to the development of several key pharmaceutical initiatives.
Postdoctoral Fellowships
Wai Chan completed two postdoctoral fellowships, enhancing his research expertise in clinical science. His first fellowship was at Eli Lilly and Company in Windlesham, UK, from 2002 to 2004. During this period, Chan engaged in pharmacological research and participated in early-phase clinical trials. Following this, he pursued another postdoctoral fellowship at UCSF from 2004 to 2006, where he further developed his research skills and contributed to various scientific publications.
Educational Background
Wai Chan holds a DPhil in Pharmacology from the University of Oxford, which he achieved between 1998 and 2001. Prior to this, he completed a BSc in Biochemistry from Imperial College London from 1995 to 1998. His rigorous academic training laid a strong foundation for his career in clinical science and research. Both degrees equipped Chan with a detailed understanding of biochemical processes and pharmacological principles, which he has applied throughout his professional journey.